Corcept Therapeutics, Inc. (CORT)
42.49
+0.51
(+1.21%)
USD |
NASDAQ |
Apr 02, 16:00
41.88
-0.61
(-1.44%)
After-Hours: 06:29
Corcept Therapeutics Profit Margin (Quarterly) : 11.83% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Merck & Co., Inc. | 18.15% |
| Terns Pharmaceuticals, Inc. | -- |
| Integer Holdings Corp. | 10.32% |
| Ultragenyx Pharmaceutical, Inc. | -62.32% |
| ACADIA Pharmaceuticals, Inc. | 96.33% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 14.97% |
| Return on Assets | 11.83% |
| Return on Invested Capital | 14.82% |
| Gross Profit Margin (Quarterly) | 98.74% |
| Operating Margin (Quarterly) | 2.22% |
| Return on Net Operating Assets | 101.3% |